Literature DB >> 18224417

Evans syndrome in a patient with Langerhans cell histiocytosis: possible pathogenesis of autoimmunity in LCH.

Yoichiro Tsuji1, Kazuhiro Kogawa, Kohsuke Imai, Hirokazu Kanegane, Junichiro Fujimoto, Shigeaki Nonoyama.   

Abstract

We report a 1-year-old girl with Evans syndrome coexisting with histologically confirmed Langerhans cell histiocytosis (LCH) affecting the cervical lymph nodes, liver, and spleen. Anti-cardiolipin antibody, anti-SS-A antibody, and anti-SS-B antibody as well as a direct antiglobulin test and platelet-associated IgG were all positive at the onset, and these autoantibodies became negative with the resolution of LCH by chemotherapy. Serum T-helper-2 (Th2) cytokine levels such as those of interleukin (IL)-6 and IL-10 were high whereas those of Th1 cytokines such as IL-2 and interferon-gamma were low at the onset, and this cytokine imbalance was normalized during the resolution of LCH. These results suggest that cytokine imbalance due to LCH led to multiple autoimmune phenomena in the present patient.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18224417     DOI: 10.1007/s12185-007-0007-x

Source DB:  PubMed          Journal:  Int J Hematol        ISSN: 0925-5710            Impact factor:   2.490


  12 in total

1.  Differential In situ cytokine profiles of Langerhans-like cells and T cells in Langerhans cell histiocytosis: abundant expression of cytokines relevant to disease and treatment.

Authors:  R M Egeler; B E Favara; M van Meurs; J D Laman; E Claassen
Journal:  Blood       Date:  1999-12-15       Impact factor: 22.113

2.  Clinical course of autoimmune hemolytic anemia: an observational study.

Authors:  Maria Christina L A Oliveira; Benigna M Oliveira; Mitiko Murao; Zilma Maria Vieira; Letícia T Gresta; Marcos B Viana
Journal:  J Pediatr (Rio J)       Date:  2006 Jan-Feb       Impact factor: 2.197

3.  Langerhans cell histiocytosis in a patient with systemic lupus erythematosus: a clonal disease responding to treatment with cladribine, and cyclophosphamide.

Authors:  Tadeusz Robak; Radzisław Kordek; Ewa Robak; Jacek Bartkowiak; Wojciech Biernat; Paweł Liberski; Jerzy Błoński
Journal:  Leuk Lymphoma       Date:  2002-10

4.  The spectrum of Evans' syndrome.

Authors:  S Savaşan; I Warrier; Y Ravindranath
Journal:  Arch Dis Child       Date:  1997-09       Impact factor: 3.791

Review 5.  Langerhans cell histiocytosis.

Authors:  R M Egeler; G J D'Angio
Journal:  J Pediatr       Date:  1995-07       Impact factor: 4.406

6.  Idiopathic central diabetes insipidus in children and young adults is commonly associated with vasopressin-cell antibodies and markers of autoimmunity.

Authors:  Mohamad Maghnie; Stefano Ghirardello; Annamaria De Bellis; Natascia di Iorgi; Linda Ambrosini; Andrea Secco; Mara De Amici; Carmine Tinelli; Antonio Bellastella; Renata Lorini
Journal:  Clin Endocrinol (Oxf)       Date:  2006-10       Impact factor: 3.478

7.  In vitro quantification of anti-red blood cell antibody production in idiopathic autoimmune haemolytic anaemia: effect of mitogen and cytokine stimulation.

Authors:  W Barcellini; G Clerici; R Montesano; E Taioli; F Morelati; P Rebulla; A Zanella
Journal:  Br J Haematol       Date:  2000-11       Impact factor: 6.998

8.  Localized thymic Langerhans' cell histiocytosis and its relationship with myasthenia gravis. Immunohistochemical, ultrastructural, and cytometric studies.

Authors:  M Z Gilcrease; B Rajan; M L Ostrowski; I Ramzy; M R Schwartz
Journal:  Arch Pathol Lab Med       Date:  1997-02       Impact factor: 5.534

9.  A case of Langerhans'-cell histiocytosis with membranous nephropathy.

Authors:  Carmit Maoz Rachima; Eytan Cohen; Nomy Levin Iaina; Ana Tobar; Moshe Garty
Journal:  Am J Kidney Dis       Date:  2004-02       Impact factor: 8.860

10.  Unmasking Evans syndrome: T-cell phenotype and apoptotic response reveal autoimmune lymphoproliferative syndrome (ALPS).

Authors:  David T Teachey; Catherine S Manno; Kelly M Axsom; Timothy Andrews; John K Choi; Barbara H Greenbaum; Joseph M McMann; Kathleen E Sullivan; Susan F Travis; Stephan A Grupp
Journal:  Blood       Date:  2004-11-12       Impact factor: 22.113

View more
  2 in total

1.  Synchronous and metachronous thyroid cancer in relation to Langerhans cell histiocytosis; involvement of V600E BRAF-mutation?

Authors:  Maria Moschovi; Maria Adamaki; Spiros Vlahopoulos; Carlos Rodriguez-Galindo
Journal:  Pediatr Blood Cancer       Date:  2014-08-22       Impact factor: 3.167

2.  Langerhans Cell Histiocytosis, Non-Langerhans histiocytosis and concurrent Papillary Thyroid Carcinoma with BRAF V600E mutations: A case report and literature review.

Authors:  Laura Wake; Liqiang Xi; Mark Raffeld; Elaine S Jaffe
Journal:  Hum Pathol (N Y)       Date:  2019-06-15
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.